Japan News
-
Takeda to stop selling 13 Pfizer products in Japan
Japan | News | By BioSpectrum Bureau | 0 Comment | 21 Jun, 2012
Singapore: Takeda Pharmaceutical and Pfizer Japan have concluded an agreement that, as of December 31, 2012, Takeda will...Read more
-
APAC's NSCLC market to show robust growth by 2019
Japan | News | By BioSpectrum Bureau | 0 Comment | 21 Mar, 2014
Singapore: The GBI Research has revealed that the non-small cell lung cancer (NSCLC) therapeutics market value in the As...Read more
-
Daiichi Sankyo to build biopharmaceuticals facility for govt
Japan | News | By BioSpectrum Bureau | 0 Comment | 13 Jul, 2012
Singapore: Daiichi Sankyo has been approved for the Japanese Ministry of Economy, Trade and Industry's production facili...Read more
-
Kyowa Hakko Kirin to return rights of Busulfex
Japan | News | By BioSpectrum Bureau | 0 Comment | 17 Sep, 2012
Singapore: Kyowa Hakko Kirin has agreed to return development and marketing rights of Busulfex, for use as a part of con...Read more
-
Which domain of clinical research do APAC CROs focus on?
Japan | Analysis | By BioSpectrum Bureau | 4 Comment | 18 Sep, 2013
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...Read more
-
Aegerion begins phase III clinical trials in Japan
Japan | News | By BioSpectrum Bureau | 0 Comment | 11 Apr, 2014
Singapore: Leading biopharmaceutical company Aegerion Pharmaceuticals that is dedicated to the development and commercia...Read more
-
Japan | Opinion | By Nandita Singh | 0 Comment | 29 May, 2013
Not long ago, it was one of India's iconic companies. Ranbaxy, which is now a subsidiary of Japanese giant Daiichi Sanky...Read more
-
Celltrion files for Remsima approval in Japan
Japan | News | By BioSpectrum Bureau | 0 Comment | 17 Sep, 2013
Singapore: Korea-based Celltrion has completed filing procedure of biosimilar drug Remsima to obtain Japan's Ministry of...Read more
-
Takeda fined $6 bn by US Federal jury
Japan | News | By BioSpectrum Bureau | 0 Comment | 11 Apr, 2014
Singapore: Japanese pharmaceutical major Takeda has been ordered by a US Federal court to pay $6 billion in punitive dam...Read more
-
Cellectricon expands to Asia with distributors in Japan
Japan | News | By BioSpectrum Bureau | 0 Comment | 06 Mar, 2013
Singapore: Cellectricon has expanded its sales and service network into Asia through a distribution agreement for its D...Read more
-
Japan's Tanabe Pharma to build new plant in China
Japan | News | By BioSpectrum Bureau | 0 Comment | 08 Aug, 2013
Singapore: Japanese drug major Mitsubishi Tanabe Pharma has announced that one of its subsidiaries, Tianjin Tanabe Seiya...Read more
-
Japanese find body 'clock' that controls jet-lag
Japan | News | By BioSpectrum Bureau | 0 Comment | 10 Oct, 2013
Singapore: Scientists at Kyoto University, Japan, have discovered the 'reset button' in the brain, which could be used t...Read more
-
Takeda resubmits NDA to the US FDA for alogliptin
Japan | Regulatory | By BioSpectrum Bureau | 1 Comment | 30 Jul, 2012
Singapore: Takeda Global Research & Development Center resubmitted New Drug Applications (NDAs) to the US FDA for al...Read more
-
St Jude launches 3-D heart vessel imager
Japan | News | By BioSpectrum Bureau | 0 Comment | 12 Mar, 2013
Singapore: St Jude Medical, a global medical device company, launched Ilumien Optis System, a next-generation technology...Read more
-
Pfizer trial of cancer drug INLYTA is a failure
Japan | News | By BioSpectrum Bureau | 0 Comment | 22 Oct, 2012
Singapore: Pfizer has revealed that its phase III study of INLYTA (axitinib) did not meet the primary endpoint of demons...Read more
-
Takeda gets Japan's approval for hypertension drug NDA
Japan | Regulatory | By BioSpectrum Bureau | 0 Comment | 27 Mar, 2014
Singapore: Takeda Pharmaceutical has recieved Japan's approval for the New Drug Application (NDA) of Zacras tablets, a f...Read more
-
Otsuka brings best-selling psychotic drug to Japan
Japan | News | By BioSpectrum Bureau | 0 Comment | 05 Sep, 2012
Singapore: Japan-based Otsuka Pharmaceutical filed an additional indication for ABILIFY (aripiprazole), as Japan's first...Read more
-
Sucampo to acquire Japan's R-Tech Ueno for $278 mn
Japan | News | By BioSpectrum Bureau | 0 Comment | 31 Aug, 2015
NASDAQ-listed Sucampo Pharmaceuticals Inc. has launched an all-cash tender offer in Japan by Sucampo's Japanese subsidia...Read more
